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Abstract Hip fracture is a common injury among the
elderly. Although patients who receive hip fracture surgery
carry the best functional recovery compared to other
treatment modalities, the presence of postoperative pulmo-
nary complications, such as atelectasis, pneumonia, and
pulmonary thromboembolism, may contribute to increased
length of hospital stay, perioperative morbidity, and
mortality. This review aims to provide evidence-based
recommendations for preoperative assessment and perio-
perative strategies to reduce the risk of pulmonary
complications after hip fracture surgery. Clinical assessment
and basic laboratory results are sufficient to stratify the risk
of postoperative pulmonary complications. Well-
documented risk factors for pulmonary complications
include advanced age, poor general health status, current
infections, pre-existing cardiopulmonary diseases, hypoal-
buminemia, and impaired renal function. Apart from
optimizing the patient's medical conditions, interventions
such as lung expansion maneuvers and thromboprophylaxis
have been proven to be effective in reducing the risk of
pulmonary complications after hip fracture surgery.
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Introduction
Hip fracture is one of the most common injuries among the
elderly with high morbidity and mortality [1]. It is
estimated that the lifetime risk of a hip fracture is 15%
among 50-year-old white women [2]. The number of hip
fractures is likely to rise in the coming decades with the
increasing life expectancy and prevalence of osteoporosis
[3]. The 1-year mortality after hip fracture is between 20%
and 35% in the elderly [4, 5]. Among those who survived at
1 year, only half of them were able to perform activities of
daily living [6]. Hip fracture surgery, including hip pinning
and hemiarthroplasty, is the mainstay treatment. It has been
shown that early hip fracture surgery (within the first 24–
48 h) is associated with better outcomes in terms of length
of stay, functional recovery, and mortality [7–9]. However,
failure to stabilize the medical conditions prior to surgery
increases the risk of postoperative cardiac and pulmonary
complications, hospital readmission, and deaths [10–12].
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surgery and adequate perioperative assessment and inter-
ventions in order to achieve better outcomes and reduce the
complications.
Postoperative pulmonary complications (PPCs) are de-
fined as pulmonary abnormalities that result in identifiable
disease or dysfunction and adversely impact the patient's
clinical course. PPCs are common and contribute to
increased length of stay, perioperative morbidity, and
mortality [13, 14]. It has been reported that pulmonary
complications affected 4% of patients after hip fracture
repair, and more than half of them were severe complica-
tions, such as pneumonia or respiratory failure [15]. A
growing body of evidence indicates that PPCs may even
predict long-term survival, especially among patients aged
70 or above [16, 17]. Clinical significant PPCs after hip
fracture surgery include atelectasis, pneumonia, pulmonary
thromboembolism, exacerbation of chronic lung disease,
respiratory failure, and acute respiratory distress syndrome
(Table 1)[ 18].
The main purposes of the preoperative pulmonary
assessment are: (1) to perform risk stratification according
to the analysis of clinical and laboratory risk factors, (2) to
determine the potential need for postoperative intensive
care, and (3) to implement interventions to reduce the risk
of PPCs [19]. While anesthetists take the leading role in
pulmonary risk assessment as part of their comprehensive
preoperative evaluation, respiratory physicians' input
should be sought to identify and manage underlying
respiratory diseases before hip fracture surgery in particular,
when there is worsening of chronic symptoms or presence
of unexplained features.
This review aims to provide evidence-based recommen-
dations for the preoperative pulmonary assessments and
perioperative interventions for patients undergoing hip
fracture surgery. Other aspects of a comprehensive preop-
erative assessment, such as cardiac, metabolic, and general
assessment, are beyond the scope of this review.
Risk factors for PPCs
Different studies may reveal diverse risk factors for PPCs,
owing to the variation in methodology such as patient
selection, sample size, and definitions of outcomes and
predictors [20]. It is also difficult to demonstrate the
independent effects of individual predictors since most of
the elderly patients have more than one risk factor. High-
quality systematic reviews and risk prediction equations
have been published to address these problems [21]. For
example, Arozullah and colleagues developed a validated
pulmonary risk index predictive of pneumonia and respira-
tory failure after non-cardiothoracic surgery [22–24]. All risk
factors for PPCs can be classified into patient-related risk
factors and procedure-related risk factors (Table 2)[ 25].
According to the risk stratification, hip fracture surgery
per se is not a high-risk operation for the development of
PPCs. However, hip fracture patients are usually elderly
with multiple co-morbidities, which make them prone to
develop PPCs. Therefore, this review focuses on the
patient-related risk factors, especially for patients with hip
fracture.
Advanced age
Advanced age (≥ 60 years) is a well-known independent risk
factor for the development of PPCs after hip fracture surgery
[21]. Earlier literature attributed the increased risk to the
growing number of concomitant diseases with aging, rather
than the effect of the chronological age itself [26]. For
example, despite a 1.8-fold increase in mortality observed
among patients older than 70 years of age compared with
those 50–70 years old, the mortality was similar among
patients in the same ASA class [27]. Recent studies have
shown that advanced age is an independent predictor for
PPCs, after controlling for the possible confounding factors
in the multivariate analysis. When patients younger than
50 years old were used as the reference, the odds ratios (OR)
for developing PPCs were 2.3, 3.9, and 5.6 for patients aged
60–69, 70–79, and ≥80 years of age, respectively [21].
Since the incidence of hip fracture increases with age and
surgeryisthemainstayoftreatment,advancedagealoneisnot
a justified reason to preclude a patient from hip fracture
surgery. Rather, patients should be evaluated for other
modifiableriskfactors andreceive perioperative interventions
to reduce the pulmonary complications after surgery.
Poor general health status
Poor general health status, including impaired sensorium
and functional dependency, increases the risk of PPCs.
Impaired sensorium is defined as either (1) an acutely
confused or delirious patient who is able to respond to
Table 1 Postoperative pulmonary complications after hip fracture
surgery
Atelectasis
Pneumonia
Pulmonary thromboembolism
Exacerbation of chronic lung disease
Respiratory failure and prolonged mechanical ventilation
Obstructive sleep apnea
Acute respiratory distress syndrome
Modified from [18]
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patient with mental status changes, delirium, or both in the
context of current illness, modestly increase the risk of
PPCs (OR 1.39) [21]. The OR of PPCs for total dependence
and partial dependence were 2.51 and 1.65, respectively
[25].
The ASA physical status grading system, which was
originally developed to describe patient's preoperative
physical status, is a powerful predictor for PPCs among
patients with COPD and asthma [28, 29]. It has long been
shown that ASA class can predict the rate of PPCs among
patients undergoing non-cardiothoracic surgery [30]. A
recent systematic review considering multiple risk factors
further confirmed that an ASA classification of 2 or higher
has an increased risk of PPCs when compared with an ASA
class of less than 2 (OR 4.87) [21].
Cigarette smoking
Cigarette smoking is a risk factor for PPCs, even in the
absence of chronic lung disease or adjusting for other co-
morbidities commonly seen in smokers [31, 32]. Current
smoker has an additional risk, and there is a correlation
between the cumulative amount of smoking and the risk of
PPCs [33]. A randomized, controlled trial has demonstrated
that patients ceased smoking for 6–8 weeks before elective
major orthopedic surgery had a reduced risk of PPCs [34].
However, the role of smoking cessation before hip fracture
surgery remains controversial. Quitters may experience a 1-
to 2-week period of increased sputum production due to the
improved respiratory mucociliary clearance [19]. Early
studies even showed a paradoxical increase in PPCs among
those patients who quit less than 6–8 weeks prior to surgery
[35, 36], though this phenomenon has not been observed in
a recent prospective study [37].
Despite the expected low impacts of smoking cessation
before hip fracture surgery on preventing PPCs, an advice
of quitting should be given to any smoker admitted to the
hospital [38]. Physicians should advise patients to start a
quit day after surgery and provide personalized counseling
and pharmacotherapy, such as nicotine replacement therapy
or varenicline, to those willing to quit [39–41].
Current respiratory infection
Current sputum production and pneumonia place the patient
at risk for the development of PPCs. Therefore, antibiotics
should be administered or hip fracture surgery should be
delayed for as long as 72 h if bacterial infection is present
in the lower respiratory tract. However, viral infection in
the upper respiratory tract does not increase the risk of
PPCs, even in asthmatic patients [29]. Prophylactic anti-
biotics covering Staphylococcus aureus, which are com-
monly given before hip fracture surgery to prevent wound
infections, are also effective in reducing the risk of
respiratory tract infection [42].
Chronic respiratory symptoms
The presence of chronic respiratory symptoms, such as
chronic cough, dyspnea, or wheeze, is common among the
elderly. In addition, diffuse rales, wheezing, or rhonchi may
be identified on chest examination before surgery. Most of
these symptoms and signs suggest the presence of under-
lying cardiopulmonary diseases, such as CHF, COPD, or
uncontrolled asthma, which will then increase the risk of
PPCs [43]. Physicians should take a detailed history and
perform a focused cardiopulmonary examination, together
with limited investigations to identify the causes of these
unexplained chronic symptoms.
Patient-related risk factors Procedure-related risk factors
Advanced age (≥60 years) Emergency surgery
Impaired sensorium Operation time≥3h
Functional dependency General anesthesia
ASA class≥2 Long-acting neuromuscular blockade use
Weight loss>10% in previous 6 months
Cigarette smoking
Current respiratory infection or sepsis
Congestive heart failure
Chronic obstructive pulmonary disease
Asthma
Obstructive sleep apnea
Ascites
Albumin level<35 g/L
Creatinine≥1.5 mg/dL or BUN≥21 mg/dL
Table 2 Risk factors for the
development of postoperative
complications related to hip
fracture surgery
ASA American Society of
Anesthesiologist, BUN blood
urea nitrogen
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galy, or interstitial changes, which represent airway diseases,
CHF, and interstitial lung diseases, respectively. Guidelines
from the American College of Physicians suggest that
spirometry should be performed in patients with unexplained
respiratory symptoms before undergoing orthopedic surgery
[44]. While spirometry with bronchodilator test is useful in
demonstrating the presence, severity, and reversibility of
airflow obstruction and, thus, differentiating asthma from
COPD, lung volume measurements are also essential in
confirming the presence of restrictive ventilatory defects,
which is suggestive of interstitial lung disease, neuromuscu-
lar disease, or chest wall deformity [45]. Echocardiography
may help to determine the systolic and diastolic heart
function and the presence of pulmonary hypertension.
Chronic obstructive pulmonary disease
The presence of COPD increases the risk of PPCs by one-
to twofold [20, 32, 46]. The increased risk in COPD
patients attributes to the airflow obstruction and the
presence of other co-morbidities commonly seen in smok-
ers, such as CHF and weight loss. A correlation has been
identified between the severity of the disease as defined by
the percentage of FEV1 of predicted value and the risk of
PPCs [47]. However, there is no prohibitive lower limit of
FEV1 or FVC, which indicates that surgery should not be
performed because operations could be safely carried out in
patients with severe COPD [48].
Physicians should optimize the management of COPD
before hip fracture surgery to minimize the risk of PPCs
[49]. The commonly used preoperative management strat-
egy can be remembered as A (antibiotic), B (bronchodila-
tor), and C (corticosteroid) [50]. Antibiotics should be
given for COPD patients with a recent change in the
purulence or amount of sputum, as it is suggestive of an
acute exacerbation caused by bacterial infection [51]. Anti-
cholinergic agents and beta2-agonists are equally effective
in reducing symptoms and airflow obstruction. The combi-
nation of these agents may provide further symptomatic
relief [52]. Long-acting bronchodilators are more effective
in reducing symptoms and airflow obstruction than their
short-acting counterparts, partially due to their anti-
inflammatory effects [53, 54]. The use of systemic
corticosteroid should be reserved for patients experiencing
an acute exacerbation or those with persistent symptoms
after maximal bronchodilators treatment [55].
Asthma
Well-controlled asthma is not a risk factor for PPCs. A
study involving 706 asthmatic patients demonstrated that
the rate of bronchospasm was just 1.7%, while one
respiratory failure and two additional laryngospasms oc-
curred during the perioperative period. There were no other
clinically significant PPCs or deaths in the entire group
[29]. However, some clinical factors, including recent
asthma symptoms, use of rescue inhalers, and medical
consultation for asthmatic attack, were associated with an
increased risk for PPCs [29].
Treatment with inhalers for asthma should be optimized
prior to hip fracture surgery. Ideally, patients should be
symptoms-free with a peak expiratory flow greater than
80% of the predicted or personal best value before surgery
[56]. A short course of systemic corticosteroid (e.g., oral
prednisone 0.5–1 mg/kg or equivalent), starting from 1 to
2 days before surgery, should be given to patients at risk for
PPCs [57]. The perioperative use of systemic corticosteroid
has not been found to increase respiratory infection or delay
wound healing among asthmatic patients [58, 59].
Obstructive sleep apnea
OSA is a syndrome characterized by periodic, partial, or
complete obstruction of the upper airway during sleep. A
case-control study showed that there is a trend towards a
higher rate of PPCs among patients with OSA undergoing
major orthopedic surgery compared with those without
[60]. The possible explanations of the increased risk of
PPCs are: (1) OSA patients may have coexisting difficult
airway and CHF, which may in turn increase the risk of
PPCs [32], and (2) the use of anesthetics and analgesics that
decrease pharyngeal tone and blunt the ventilatory response
to hypoxia, together with supine positioning, may aggravate
the severity of OSA during the perioperative period [61].
Patients should be screened for OSA before hip fracture
surgery. Physicians should judge the probability of OSA
based on the presence of risk factors and validated
questionnaires. Major risk factors for OSA include male
gender, obesity (body mass index >35 kg/m
2), wide neck
(neck circumference>40 cm), crowded oropharynx, and
craniofacial abnormalities affecting the upper airway [62].
A four-question questionnaire known as “STOP” has been
validated in screening perioperative patients for OSA [63].
Patients at risk for OSA should be asked the following four
questions:
1. Snore: Do you snore loudly?
2. Tired: Do you often feel tired, fatigued, or sleepy
during the day?
3. Observed: Has anyone observed you stop breathing
during your sleep?
4. Blood pressure: Do you have or are you being treated
for hypertension?
Ifapatientanswersyesfortwoormorequestions,heorshe
is at high risk for OSA. Continuous positive airway pressure
S582 Osteoporos Int (2010) 21 (Suppl 4):S579–S586(CPAP), the mainstay treatment for OSA, may be considered
during the perioperative period, and elective polysomnogra-
phy should be arranged later on [64]. For those with known
OSA prior to hip fracture, adequate treatment, such as CPAP,
mandibular advancement device, or oral appliances, should
be provided as recommended by the guidelines from the
American Society of Anaesthesiologists [62].
Other chronic lung diseases
Although other chronic lung diseases such as interstitial
lung disease, neuromuscular disease, chest wall deformity,
or pulmonary artery hypertension may increase the risk of
PPCs after lung resection and other non-cardiothoracic
surgery [65, 66], there is no strong evidence suggesting an
increased risk for pulmonary complications after hip
fracture surgery among patients with these conditions [25].
Preoperative tests
Preoperative tests such as chest radiograph, spirometry, or
arterial blood gas should not be ordered as a routine before
hip fracture surgery since the results of these tests have
little impact on the perioperative management [25].
Chest radiograph
Routine chest radiograph should not be done for patients
with hip fracture. A meta-analysis of studies involving
14,390 preoperative chest radiographs found that only 14
cases with chest radiographs were unexpectedly abnormal
and management was changed [67]. Another study demon-
strated that, despite a lower rate of PPCs in patients who
received preoperative chest radiograph (12.8% vs 16%),
only 1–4% of the patients' managements were altered due
to the result of chest radiograph [68]. Chest radiograph is
only indicated in: (1) patients with unexplained respiratory
symptoms or (2) suspected lower respiratory tract infection
based on clinical findings.
Spirometry and arterial blood gas
Routine preoperative spirometry plays very little or no role in
patients with hip fracture [25]. The predictive value of
spirometry for PPCs is not better than those of clinical
findings such as history and physical examination [69, 70].
Guidelines recommend that preoperative spirometry is
indicated in patients with unexplained respiratory symptoms
before undergoing orthopedic surgery [44]. Spirometry is
also helpful in determining whether patients with COPD or
asthma are under optimal control before surgery. Early
studies indicated that a partial pressure of arterial carbon
dioxide (PaCO2) greater than 45 mmHg increases the risk of
PPCs [71, 72]. However, later studies have not shown the
association between a raised PaCO2 and the PPCs risk [73].
Risk-reduction interventions
All patients at risk of PPCs should receive perioperative
interventions in order to reduce PPCs. Apart from employ-
ing specific risk-reduction strategies to the above-
mentioned risk factors, physicians should implement
general interventions, such as lung expansion maneuvers,
thromboprophylaxis, and regional anesthesia/analgesia to
reduce the risk of PPCs [74].
Lung expansion techniques
Lung expansion techniques, including deep-breathing exer-
cises and incentive spirometry, are effective in reducing the
risk of PPCs. Training on lung-expansion techniques should
be provided to all patients at risk of PPCs. It has been
shown that teaching patients these techniques preoperative-
ly reduces pulmonary complications to a greater extent than
instructions given after surgery [75]. Deep-breathing exer-
cises and incentive spirometry are equally effective in
reducing the risk of PPCs, and the latter is less labor-
intensive [76]. A review found that these techniques
consistently reduced the relative risk of pulmonary compli-
cations by approximately 50% [77]. If patients at high-risk
of PPCs are not able to perform these techniques,
postoperative CPAP is a good alternative [78, 79].
Prophylaxis for venous thromboembolism
Patients with hip fracture are at high risk for the
development of venous thromboembolism (VTE), includ-
ing deep-vein thrombosis (DVT) and subsequent pulmo-
nary embolism. Guidelines from the American College of
Chest Physicians recommend that thromboprophylaxis
should be administered among all patients undergoing hip
fracture surgery for 10–35 days [80]. The drugs of choice
include synthetic pentasaccharide (e.g., fondaparinux), low-
molecular-weight heparin (LMWH), low-dose unfractio-
nated heparin (LDUH), and vitamin K antagonist (e.g.,
warfarin, targeting INR 2 to 3).
As concern for the timing of initiation, it is common to
start thromboprophylaxis before surgery because DVT may
begin during surgery [81]. However, recent evidence favors
starting thromboprophylaxis after surgery due to the
following reasons: (1) it provides comparable protection
to the preoperative initiation of thromboprophylaxis [82],
(2) it does not interfere with decisions about the use of
regional anesthesia, and (3) it does not contribute to
intraoperative bleeding. For hip fracture patients whose
Osteoporos Int (2010) 21 (Suppl 4):S579–S586 S583surgery is likely to be delayed, thromboprophylaxis with
short-acting anticoagulant (e.g., LMWH or LDUH) should
be initiated during the interval between hospital admission
and surgery [80]. It should be noted that symptomatic
breakthrough VTE, primarily distal DVT, may develop in
9% of patients undergoing hip fracture surgery despite
standard thromboprophylaxis [83].
Recent studies have shown that dabigatran etexilate, an
oral direct thrombin inhibitor not requiring frequent
laboratory monitoring as warfarin, is at least as effective
as LMWH for the prevention of VTE following major
orthopedic surgery [84, 85]. For patients with high risk of
bleeding or contraindications to any form of anticoagula-
tion, mechanical prophylactic measures, such as pneumatic
sequential leg compression or graduated compression
stockings should be given [86].
Regional anesthesia and analgesia
A meta-analysis involving 141 randomized controlled trials
reported that patients receiving regional anesthesia (either
spinal or epidural anesthesia) had lower rates of pneumonia
and respiratory failure as compared with those under
general anesthesia [87]. However, another systematic
review involving 15 randomized trials of 2,162 patients
focusing on hip fracture surgery found that the postopera-
tive pneumonia rates were almost the same (5.1% in
regional vs 5.5% in general anesthesia) [88].
Postoperative epidural analgesia is associated with the
lowest rate of PPCs compared with other forms of analgesia
among patients after major abdominal surgery [21].
However, to date, there seems to have been no study
investigating the difference in PPCs among those patients
undergoing hip fracture surgery. Further investigations are
needed to demonstrate the beneficial effects of regional
anesthetics and analgesics on PPCs among patients receiv-
ing hip fracture surgery. It is conceivable that spinal/
epidural hematoma may occur in anticoagulated patients
who are receiving regional anesthesia or analgesia. How-
ever, a recent study found that well-controlled anticoagu-
lation was not associated with an increased risk of
postoperative spinal/epidural hematoma [89].
Conclusion
Hip fracture is a common cause of morbidity and mortality
among the elderly. PPCs play an important role in altering the
risk for patients undergoing hip fracture surgery. Physicians
should perform preoperative pulmonary assessment, taking
into account the patient-related risk factors such as advanced
age, poor general health status, current infections, underlying
cardiopulmonary diseases, hypoalbuminemia, and impaired
renal function. At the same time, efforts should be made to
optimizethepatient's medical conditions prior to surgery, and
preoperative interventions such as lung expansion techniques
and thromboprophylaxis should be employed in order to
minimize the pulmonary risk.
Conflicts of interest None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Dharmarajan TS, Banik P (2006) Hip fracture. Risk factors,
preoperative assessment, and postoperative management. Postgrad
Med 119:31–38
2. Cooper C, Campion G, Melton LJ (1992) Hip fractures in the
elderly: a world-wide projection. Osteoporos Int 2:285–289
3. Raaymakers EL (2006) Fractures of the femoral neck: a review and
personal statement. Acta Chir Orthop Traumatol Cech 73:45–59
4. Lu-Yao GL, Baron JA, Barrett JA, Fischer ES (1994) Treatment
and survival among elderly Americans with hip fractures: a
population-based study. Am J Public Health 84:1287–1291
5. Goldacre MJ, Roberts SE, Yeates D (2002) Mortality after
admission to hospital with fractured neck of femur: database
study. BMJ 325:868–869
6. Magaziner J, Simonsick EM, Kashner TM, Hebel JR, Kenzora JE
(1990) Predictors of functional recovery one year following
hospital discharge for hip fracture: a prospective study. J Gerontol
45:M101–M107
7. Orosz GM, Magaziner J, Hannan EL et al (2004) Association of
timing of surgery for hip fracture and patient outcomes. JAMA
291:1738–1743
8. Bottle A, AylinP (2006)Mortality associatedwith delay inoperation
after hip fracture: observational study. BMJ 332:947–951
9. Shiga T, Wajima Z, Ohe Y (2008) Is operative delay associated with
increased mortality ofhip fracture patients?Systematicreview,meta-
analysis, and meta-regression. Can J Anaesth 55:146–154
10. Lawrence VA, Hilsenbeck SG, Mulrow CD, Dhanda R, Sapp J,
Page CP (1995) Incidence and hospital stay for cardiac and
pulmonary complications after abdominal surgery. J Gen Intern
Med 10:671–678
11. French DD, Bass E, Bradham DD, Campbell RR, Rubenstein LZ
(2008) Rehospitalization after hip fracture: predictors and prognosis
from a national veterans study. J Am Geriatr Soc 56:705–710
12. Yonezawa T, Yamazaki K, Atsumi T, Obara S (2009) Influence of
the timing of surgery on mortality and activity of hip fracture in
elderly patients. J Orthop Sci 14:566–573
13. Smetana GW (1999) Preoperative pulmonary evaluation. N Engl J
Med 340:937–944
14. Liu LL, Leung JM (2000) Predicting adverse postoperative
outcomes in patients aged 80 years or older. J Am Geriatr Soc
48:405–412
15. Lawrence VA, Hilsenbeck SG, Noveck H, Poses RM, Carson JL
(2002) Medical complications and outcomes after hip fracture
repair. Arch Intern Med 162:2053–2057
S584 Osteoporos Int (2010) 21 (Suppl 4):S579–S58616. Manku K, Bacchetti P, Leung JM (2003) Prognostic significance
of postoperative inhospital complications in elderly patients. I.
Long-term survival. Anesth Analg 96:583–589
17. Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA,
Kumbhani DJ (2005) Determinants of long-term survival after
major surgery and the adverse effect of postoperative complica-
tions. Ann Surg 242:326–341
18. Swenson ER (2004) Preoperative pulmonary evaluation. In:
Albert RK, Spiro S, Jett J (eds) Clinical respiratory medicine,
2nd edn. Elsevier Science, Philadelphia, pp 229–234
19. Smetana GW (2003) Preoperative pulmonary assessment of the
older adult. Clin Geriatr Med 19:35–55
20. Fisher BW, Majumdar SR, McAlister FA (2002) Predicting
pulmonary complications after nonthoracic surgery: a systematic
review of blinded studies. Am J Med 112:219–225
21. Smetana GW, Lawrence VA, Cornell JE (2006) Preoperative
pulmonary risk stratification for noncardiothoracic surgery:
systematic review for the American College of Physicians. Ann
Intern Med 144:581–595
22. Arozullah AM, Daley J, Henderson WG, Khuri SF (2000)
Multifactorial risk index for predicting postoperative respiratory
failure in men after major noncardiac surgery: the National
Veterans Administration Surgical Quality Improvement Program.
Ann Surg 232:242–253
23. Arozullah AM, Khuri SF, Henderson WG, Daley J (2001)
Development and validation of a multifactorial risk index for
predicting postoperative pneumonia after major noncardiac sur-
gery. Ann Intern Med 135:847–857
24. Johnson RG, Arozullah AM, Neumayer L, Henderson WG,
Hosokawa P, Khuri SF (2007) Multivariable predictors of
postoperative respiratory failure after general and vascular
surgery: results from the patient safety in surgery study. J Am
Coll Surg 204:1188–1198
25. Qaseem A, Snow V, Fitterman N et al (2006) Risk assessment for
and strategies to reduce perioperative pulmonary complications
for patients undergoing noncardiothoracic surgery: a guideline
from the American College of Physicians. Ann Intern Med
144:575–580
26. Polanczyk CA, Marcantonio E, Goldman L, Rohde LE, Orav J,
Mangione CM, Lee TH (2001) Impact of age on perioperative
complications and length of stay in patients undergoing noncar-
diac surgery. Ann Intern Med 134:637–643
27. Marx GF, Mateo CV, Orkin LR (1973) Computer analysis of
postanesthetic deaths. Anesthesiology 39:54–58
28. Wong D, Weber EC, Schell MJ, Wong AB, Anderson CT, Barker
SJ (1995) Factors associated with postoperative pulmonary
complications in patients with severe chronic obstructive pulmo-
nary disease. Anesth Analg 80:276–284
29. Warner DO, Warner MA, Barnes RD, Offord KP, Schroeder DR,
Gray DT, Yunginger JW (1996) Perioperative respiratory compli-
cations in patients with asthma. Anesthesiology 85:460–467
30. Owens WD, Felts JA, Spitznagel EL Jr (1978) ASA physical
status classifications: a study of consistency of ratings. Anesthe-
siology 49:239–243
31. Warner DO (2006) Perioperative abstinence from cigarettes.
Anesthesiology 104:356–67
32. McAlister FA, Khan NA, Straus SE, Papaioakim M, Fisher BW,
Majumdar SR, Gajic O, Daniel M, Tomlinson G (2003) Accuracy
of the preoperative assessment in predicting pulmonary risk after
nonthoracic surgery. Am J Respir Crit Care Med 167:741–744
33. Warner MA, Divertie MB, Tinker JH (1984) Preoperative
cessation of smoking and pulmonary complications in coronary
artery bypass patients. Anesthesiology 60:380–383
34. Møller AM, Villebro N, Pedersen T, Tønnesen H (2002) Effect of
preoperative smoking intervention on postoperative complica-
tions: a randomized clinical trial. Lancet 359:114–117
35. Warner MA, Offord KP, Warner ME, Lennon RL, Conover MA,
Jansson-Schumacher U (1989) Role of preoperative cessation of
smoking and other factors in postoperative pulmonary complica-
tions: a blinded prospective study of coronary artery bypass
patients. Mayo Clin Proc 64:609–616
36. Bluman LG, Mosca L, Newman N, Simon DG (1998) Preoper-
ative smoking habits and postoperative pulmonary complications.
Chest 113:883–889
37. Barrera R, Shi W, Amar D, Thaler HT, Gabovich N, Bains MS,
White DA (2005) Smoking and timing of cessation: impact on
pulmonary complications after thoracotomy. Chest 127:1977–
1983
38. Clinical Practice Guideline Treating Tobacco Use and Depen-
dence 2008 Update Panel, Liaisons, and Staff (2008) A clinical
practice guideline for treating tobacco use and dependence: 2008
update. A U.S. Public Health Service report. Am J Prev Med
35:158–176
39. Niaura R (2008) Non-pharmacologic therapy for smoking
cessation: characteristics and efficacy of current approaches. Am
J Med 131:S11–S19
40. Stead LF, Perera R, Bullen C et al (2008) Nicotine replacement
therapy for smoking cessation. Cochrane Database Syst Rev 1:
CD000146
41. Hays JT, Ebbert JO (2008) Varenicline for tobacco dependence. N
Engl J Med 359:2018–2014
42. Gillespie WJ, Walenkamp GH (2010) Antibiotic prophylaxis for
surgery for proximal femoral and other closed long bone fractures.
Cochrane Database Syst Rev 3:CD000244
43. Epstein SK, Faling LJ, Daly BD, Celli BR (1993) Predicting
complications after pulmonary resection: preoperative exercise
testing vs a multifactorial cardiopulmonary risk index. Chest
104:694–700
44. American College of Physicians (1990) Preoperative pulmonary
function testing. Ann Intern Med 112:793–794
45. Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative
strategies for lung function tests. Eur Respir J 26:948–968
46. Warner DO, Warner MA, Offord KP, Schroeder DR, Maxson P,
Scanlon PD (1999) Airway obstruction and perioperative compli-
cations in smokers undergoing abdominal surgery. Anesthesiology
90:372–379
47. Gass GD, Olsen GN (1986) Preoperative pulmonary function
testing to predict postoperative morbidity and mortality. Chest
89:127–135
48. Kroenke K, Lawrence VA, Theroux JF, Tuley MR (1992)
Operative risk in patients with severe obstructive pulmonary
disease. Arch Intern Med 152:967–971
49. Alifano M, Cuvelier A, Roche DN, Lamia B, Molano LC,
Couderc LJ, Marquette CH, Devillier P (2010) Treatment of
COPD: from pharmacological to instrumental therapies. Eur
Respir Rev 19:7–23
50. Rabe KF, Hurd S, Anzueto A et al (2007) Global strategy for the
diagnosis, management, and prevention of chronic obstructive
pulmonary disease: GOLD executive summary. Am J Respir Crit
Care Med 176:532–555
51. Wilson R, Jones P, Schaberg T, Arvis P, Duprat-Lomon I, Sagnier
PP (2006) Antibiotic treatment and factors influencing short and
long term outcomes of acute exacerbations of chronic bronchitis.
Thorax 61:337–342
52. McCrory DC, Brown CD (2002) Anti-cholinergic bronchodilators
versus beta2-sympathomimetic agents for acute exacerbations of
chronic obstructive pulmonary disease. Cochrane Database Syst
Rev 4:CD003900
53. Johnson M, Rennard S (2001) Alternative mechanisms for long-
acting beta2-adrenergic agonists in COPD. Chest 120:258–270
54. Buhling F, Lieder N, Reisenauer A, Welte T (2004) Antiinflam-
matory effect of tiotropium mediated by suppression of
Osteoporos Int (2010) 21 (Suppl 4):S579–S586 S585acetylcholine-induced release of chemotactic activity. Eur Respir J
24:318S
55. Davies L, Angus RM, Calverley PM (1999) Oral corticosteroids
in patients admitted to hospital with exacerbations of chronic
obstructive pulmonary disease: a prospective randomised con-
trolled trial. Lancet 354:456–460
56. Bateman ED, Hurd SS, Barnes PJ et al (2008) Global strategy for
asthma management and prevention: GINA executive summary.
Eur Respir J 31:143–178
57. Silvanus MT, Groeben H, Peters J (2004) Corticosteroids and
inhaled salbutamol in patients with reversible airway obstruction
markedly decrease the incidence of bronchospasm after tracheal
intubation. Anesthesiology 100:1052–1057
58. Pien LC, Grammer LC, Patterson R (1988) Minimal complica-
tions in a surgical population with severe asthma receiving
prophylactic corticosteroids. J Allergy Clin Immunol 82:696–700
59. Kabalin CS, Yarnold PR, Grammer LC (1995) Low complication
rate of corticosteroid-treated asthmatics undergoing surgical
procedures. Arch Intern Med 155:1379–1384
60. Grupta R, Parvizi J, Hanssen A, Gay P (2001) Postoperative
complications in patients with obstructive sleep apnea syndrome
undergoing hip or knee replacement: a case-control study. Mayo
Clin Proc 76:897–905
61. Rock P, Passannante A (2004) Preoperative assessment: pulmo-
nary. Anesthesiol Clin N Am 22:77–91
62. American Society of Anesthesiologists Task Force on Perioper-
ative Management of Patients with Obstructive Sleep Apnea
(2006) Practice guidelines for the perioperative management of
patients with obstructive sleep apnea. Anesthesiology 104:1081–
1093
63. Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S,
Islam S, Khajehdehi A, Shapiro CM (2008) STOP questionnaire:
a tool to screen patients for obstructive sleep apnea. Anesthesi-
ology 108:812–821
64. Ulnick K, Debo R (2000) Postoperative management of the
patient with obstructive sleep apnea. Otolaryngol Head Neck Surg
122:233–236
65. Martinod E, Azorin JF, Sadoun D, Destable MD, Le Toumelin P,
Longchampt E, Kambouchner M, Guillevin L, Valeyre D (2002)
Surgical resection of lung cancer in patients with underlying
interstitial lung disease. Ann Thorac Surg 74:1004–1007
66. Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon
MD (2005) Impact of pulmonary hypertension on the outcomes of
noncardiac surgery: predictors of perioperative morbidity and
mortality. J Am Coll Cardiol 45:1691–1699
67. Archer C, Levy AR, McGregor M (2003) Value of routine
preoperative chest x-rays: a meta-analysis. Can J Anaesth
40:1022–1027
68. Joo HS, Wong J, Naik VN, Savoldelli GL (2005) The value of
screening preoperative chest x-rays: a systematic review. Can J
Anaesth 52:568–574
69. Williams-Russo P, Charlson ME, MacKenzie CR, Gold JP, Shires
GT (1992) Predicting postoperative pulmonary complications: is it
a real problem? Arch Intern Med 152:1209–1213
70. Lawrence VA, Dhanda R, Hilsenbeck SG, Page CP (1996) Risk of
pulmonary complications after elective abdominal surgery. Chest
110:744–750
71. Milledge JS, Nunn JF (1975) Criteria of fitness for anaesthesia in
patients with chronic obstructive lung disease. BMJ 3:670–673
72. Stein M, Koota GM, Simon M, Frank HA (1962) Pulmonary
evaluation of surgical patients. JAMA 181:765–770
73. Kearney DJ, Lee TH, Reilly JJ, DeCamp MM, Sugarbaker DJ
(1994) Assessment of operative risk in patients undergoing lung
resection: importance of predicted pulmonary function. Chest
105:753–759
74. Lawrence VA, Cornell JE, Smetana GW (2005) Strategies to
reduce postoperative pulmonary complications after noncardio-
thoracic surgery: systematic review for the American College of
Physicians. Ann Intern Med 144:596–608
75. Castillo R, Haas A (1985) Chest physical therapy: comparative
efficacy of preoperative and postoperative in the elderly. Arch
Phys Med Rehabil 66:376–379
76. Thomas JA, McIntosh JM (1994) Are incentive spirometry,
intermittent positive pressure breathing, and deep breathing
exercises effective in the prevention of postoperative pulmonary
complications after upper abdominal surgery? A systematic
overview and meta-analysis. Phys Ther 74:3–16
77. Brooks-Brunn JA (1995) Postoperative atelectasis and pneumonia.
Heart Lung 24:94–115
78. Stock MC, Downs JB, Gauer PK, Alster JM, Imrey PB (1985)
Prevention of postoperative pulmonary complications with CPAP,
incentive spirometry, and conservative therapy. Chest 87:151–157
79. Squadrone V, Coha M, Cerutti E et al (2005) Continuous positive
airway pressure for treatment of postoperative hypoxemia: a
randomized controlled trial. JAMA 293:589–595
80. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM,
Lassen MR, Colwell CW (2008) Prevention of venous thrombo-
embolism: American College of Chest Physicians Evidence-Based
Clinical Practice Guidelines (8th Edition). Chest 133:381S–453S
81. Morrison RS, Chassin MR, Siu AL (1998) The medical
consultant’s role in caring for patients with hip fracture. Ann
Intern Med 128:1010–1020
82. Hull RD, Pineo GF, Francis C et al (2000) Low-molecular-weight
heparin prophylaxis using dalteparin in close proximity to surgery
vs warfarin in hip arthroplasty patients: a doubleblind, randomized
comparison. Arch Intern Med 160:2199–2207
83. Schiff RL, Kahn SR, Shrier I, Strulovitch C, Hammouda W,
Cohen E, Zukor D (2005) Identifying orthopedic patients at high
risk for venous thromboembolism despite thromboprophylaxis.
Chest 128:3364–3371
84. Eriksson BI, Dahl OE, Rosencher N et al (2007) Dabigatran
etexilate versus enoxaparin for prevention of venous thromboem-
bolism after total hip replacement: a randomised, double-blind,
non-inferiority trial. Lancet 370:949–956
85. Eriksson BI, Dahl OE, Rosencher N et al (2007) Oral dabigatran
etexilate vs. subcutaneous enoxaparin for the prevention of venous
thromboembolism after total knee replacement: the RE-MODEL
randomized trial. J Thromb Haemost 5:2178–2185
86. Handoll HH, Farrar MJ, McBirnie J, Tytherleigh-Strong G, Milne
AA, Gillespie WJ (2002) Heparin, low molecular weight heparin
and physical methods for preventing deep vein thrombosis and
pulmonary embolism following surgery for hip fractures.
Cochrane Database Syst Rev 4:CD000305
87. Rodgers A, Walker N, Schug S et al (2000) Reduction of postoperative
mortality and morbidity with epidural or spinal anaesthesia: results
from overview of randomised trials. BMJ 321:1493
88. Urwin SC, Parker MJ, Griffiths R (2000) General versus regional
anaesthesia for hip fracture surgery: a meta-analysis of random-
ized trials. Br J Anaesth 84:450–455
89. Awad JN, Kebaish KM, Donigan J, Cohen DB, Kostuik JP (2005)
Analysis of the risk factors for the development of post-operative
spinal epidural hematoma. J Bone Joint Surg Br 87:1248–1252
S586 Osteoporos Int (2010) 21 (Suppl 4):S579–S586